Abir K. Panda

678 total citations
18 papers, 546 citations indexed

About

Abir K. Panda is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Abir K. Panda has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Abir K. Panda's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (6 papers). Abir K. Panda is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (6 papers). Abir K. Panda collaborates with scholars based in India and United States. Abir K. Panda's co-authors include Gaurisankar Sa, Sayantan Bose, Irene Sarkar, Tila Khan, Shravanti Mukherjee, Deblina Guha, Tania Sarkar, Sreeparna Chakraborty, Diptendra Kumar Sarkar and Subhrangsu Chatterjee and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Scientific Reports.

In The Last Decade

Abir K. Panda

16 papers receiving 533 citations

Peers

Abir K. Panda

IMMUN

ONCOL

Juni Chakraborty India

Vinod Balachandran India

Ankur Karmokar United Kingdom

Lavinia Lupuţ Romania

Jin-Jin Lin Taiwan

Chinenye Iwuji United Kingdom

Peter H. Killian Germany

Anna‐Lena Mueller Germany

Fardin Hashemi Iran

Ping Pei United States

Juni Chakraborty India

Abir K. Panda

253 ×1.2

94 ×0.5

IMMUN

123 ×0.7

108 ×0.8

ONCOL

59 ×1.0

Citations per year, relative to Abir K. Panda Abir K. Panda (= 1×) peers Juni Chakraborty

Countries citing papers authored by Abir K. Panda

Since Specialization

Citations

This map shows the geographic impact of Abir K. Panda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abir K. Panda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abir K. Panda more than expected).

Fields of papers citing papers by Abir K. Panda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abir K. Panda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abir K. Panda. The network helps show where Abir K. Panda may publish in the future.

Co-authorship network of co-authors of Abir K. Panda

This figure shows the co-authorship network connecting the top 25 collaborators of Abir K. Panda. A scholar is included among the top collaborators of Abir K. Panda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abir K. Panda. Abir K. Panda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Panda, Abir K., Kannan Natarajan, Jiansheng Jiang, et al.. (2025). Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity. Cancer Immunology Research. 13(12). 1938–1955.

Kim, Yong‐Hee, Abir K. Panda, & Ethan M. Shevach. (2025). Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis. European Journal of Immunology. 55(5). e202551771–e202551771.

Sarkar, Tania, et al.. (2024). FOXP3 Transcriptionally Activates Fatty Acid Scavenger Receptor CD36 in Tumour‐Induced Treg Cells. Immunology. 174(3). 296–309. 5 indexed citations

Sarkar, Tania, Sayantan Bose, Abir K. Panda, et al.. (2022). FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer. Frontiers in Immunology. 13. 740588–740588. 45 indexed citations

Panda, Abir K., et al.. (2022). Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation. The Journal of Immunology. 208(4). 851–860. 16 indexed citations

Bose, Sayantan, Abir K. Panda, Sreeparna Chakraborty, et al.. (2021). Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients. Cancer Immunology Immunotherapy. 70(7). 1877–1891. 19 indexed citations

Panda, Abir K., Surajit Sinha, Natarajan Kannan, et al.. (2021). Global inhibition of the interaction of NK inhibitory receptors with MHC-I augments coordinated innate and adaptive immunity against cancer metastasis. The Journal of Immunology. 206(1_Supplement). 57.11–57.11. 1 indexed citations

Panda, Abir K., Arunakumar Gangaplara, Maja Buszko, et al.. (2020). Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity. The Journal of Immunology. 205(3). 567–572. 7 indexed citations

Panda, Abir K. & Ethan M. Shevach. (2019). Inhibition of NK cell-MHCI interactions disrupts immune homeostasis by activation of the IFNγ/IL15 axis resulting in augmentation of anti-tumor immunity. The Journal of Immunology. 202(1_Supplement). 194.4–194.4. 1 indexed citations

10.

Panda, Abir K., Jyotsna Bhat, Sayantan Bose, et al.. (2019). Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis. Scientific Reports. 9(1). 4073–4073. 33 indexed citations

11.

Chakraborty, Sreeparna, et al.. (2018). Providence of the CD25⁺KIR⁺CD127⁻FOXP3⁻CD8⁺ T‐cell subset determines the dynamics of tumor immune surveillance. Immunology and Cell Biology. 96(10). 1035–1048. 5 indexed citations

12.

Panda, Abir K., et al.. (2017). New insights into therapeutic activity and anticancer properties of curcumin. Journal of Experimental Pharmacology. Volume 9. 31–45. 172 indexed citations

13.

Chakraborty, Sreeparna, et al.. (2017). Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. Scientific Reports. 7(1). 1628–1628. 44 indexed citations

14.

Banerjee, Shuvomoy, Pushpak Bhattacharjee, Juni Chakraborty, et al.. (2017). WITHDRAWN: Curcumin shifts RAS-induced pro-proliferative MEK/ERK-signaling toward pro-apoptotic p38MAPK/JNK1-signaling, triggering p53 activation and apoptosis. Journal of Biological Chemistry. jbc.M117.784868–jbc.M117.784868. 5 indexed citations

15.

Panda, Abir K., Sayantan Bose, Tania Sarkar, et al.. (2017). Cancer-immune therapy: restoration of immune response in cancer by immune cell modulation. The Nucleus. 60(2). 93–109. 3 indexed citations

16.

Saha, Taniya, Deblina Guha, Argha Manna, et al.. (2016). G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53. Scientific Reports. 6(1). 32626–32626. 24 indexed citations

17.

Bose, Sayantan, Abir K. Panda, Shravanti Mukherjee, & Gaurisankar Sa. (2015). Curcumin and tumor immune-editing: resurrecting the immune system. Cell Division. 10(1). 6–6. 126 indexed citations

18.

Hossain, Dewan Md Sakib, Abir K. Panda, Pushpak Bhattacharjee, et al.. (2014). MEK inhibition prevents tumour‐shed transforming growth factor‐β‐induced T‐regulatory cell augmentation in tumour milieu. Immunology. 144(4). 561–573. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact